Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

23.02.2026

1 BMC Surg
1 Cancer
2 Clin Cancer Res
1 Dis Esophagus
2 Head Neck
1 Int J Cancer
4 Int J Radiat Oncol Biol Phys
3 J Clin Endocrinol Metab
1 J Laryngol Otol
4 Laryngoscope
11 Oral Oncol
2 PLoS One
1 Radiother Oncol


    BMC Surg

  1. MATLIM OZEL T, Yilmaz M, Akbulut S, Celik A, et al
    Papillary thyroid carcinoma in graves' disease: prevalence, clinicopathological features, and preoperative predictors.
    BMC Surg. 2026 Feb 17. doi: 10.1186/s12893-026-03602.
    >> Share


    Cancer

  2. YANO Y, Tota JE, Graubard BI, Liao LM, et al
    Etiologic heterogeneity across oral cavity cancers.
    Cancer. 2026;132:e70309.
    >> Share


    Clin Cancer Res

  3. MIERZWA M, Rosen B, Suresh K, Dinesh A, et al
    FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial.
    Clin Cancer Res. 2026;32:684-693.
    >> Share

  4. LI JZ, Ricarte Filho J, Isaza AR, Hinkle K, et al
    DNA Methylation-based Risk Stratification and Classification of Pediatric Thyroid Carcinoma.
    Clin Cancer Res. 2026 Feb 17. doi: 10.1158/1078-0432.CCR-25-2109.
    >> Share


    Dis Esophagus

  5. LIU C, Lee YY, Chien LI, Tao ZX, et al
    Nutritional and prognostic effects of thoracic duct obliteration during esophagectomy.
    Dis Esophagus. 2026;39:doag010.
    >> Share


    Head Neck

  6. BLYTH K, Tam J, Robinson R, Stone D, et al
    A Student-Led Tele-Expiratory Muscle Strength Training (EMST) Program for Head and Neck Cancer (HNC) Survivors-A Pilot Implementation Study.
    Head Neck. 2026 Feb 20. doi: 10.1002/hed.70206.
    >> Share

  7. WU SS, Ayoub NF, Chen MM, Finegersh A, et al
    Cost Comparison of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection in Early-Stage Oral Cavity Squamous Cell Carcinoma.
    Head Neck. 2026 Feb 16. doi: 10.1002/hed.70200.
    >> Share


    Int J Cancer

  8. CUI Z, Zhao Y, Xu Q, Zhao R, et al
    Multilevel pathways to esophageal cancer: Population attributable risks of modifiable exposures, surrogate blood biomarkers, and genetic susceptibility, and the mediation effects based on a 10-year prospective cohort study.
    Int J Cancer. 2026 Feb 16. doi: 10.1002/ijc.70383.
    >> Share


    Int J Radiat Oncol Biol Phys

  9. RAAIJMAKERS KTPM, Peters RHW, Beekmans M, Beerkens APM, et al
    Head and Neck Squamous Cell Carcinoma patient-derived Cancer-Associated Fibroblasts undergo senescence while retaining pro-tumorigenic properties after ex vivo irradiation.
    Int J Radiat Oncol Biol Phys. 2026 Feb 14:S0360-3016(26)00395.
    >> Share

  10. CUBERO L, Acosta O, Pascau J, Palard-Novello X, et al
    Voxel-based analysis identifies new functional subregions predictive of xerostomia after head and neck cancer radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 16:S0360-3016(26)00374.
    >> Share

  11. BENTZEN SM, Gupta T, Jacinto AA, Rosenblatt E, et al
    Hypofractionated Versus Normofractionated Accelerated Radiation Therapy With or Without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO): A Randomized, Open-Label, Phase 3, Noninferiority Trial.
    Int J Radiat Oncol Biol Phys. 2026 Feb 18:S0360-3016(26)00020.
    >> Share

  12. YANG Y, Jiang Y, Wang C, Li J, et al
    Randomized Study on Different Radiation Doses in Neoadjuvant Chemoradiotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma (Neo-DRATEC Trial).
    Int J Radiat Oncol Biol Phys. 2026 Feb 17:S0360-3016(26)00390.
    >> Share


    J Clin Endocrinol Metab

  13. LEE JS, Kim NK, Jeong HJ, Yun HJ, et al
    Impact of Subtype Variability on Clinical Features in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2025 Nov 19:dgaf531. doi: 10.1210.
    >> Share

  14. VALENCIAGA A, Liyanarachchi S, Brock PL, Ringel MD, et al
    Long-term outcomes of patients diagnosed with differentiated thyroid cancer in childhood and young adulthood.
    J Clin Endocrinol Metab. 2025 Sep 18:dgaf522. doi: 10.1210.
    >> Share

  15. REDLICH A, Pfaehler E, Kunstreich M, Schmutz M, et al
    ML Prediction of Recurrence in Pediatric Thyroid Cancer: MET Cohort Analysis Using XGBoost and SHAP.
    J Clin Endocrinol Metab. 2025 Sep 1:dgaf487. doi: 10.1210.
    >> Share


    J Laryngol Otol

  16. WIJAYARATHNA R, Jones GD, Ringshall S, Suh ES, et al
    The incidence of respiratory infections in patients undergoing major oral cavity and maxillary and mandibular resections with free flap reconstruction for head and neck cancer.
    J Laryngol Otol. 2026 Feb 18:1-17. doi: 10.1017/S0022215125104131.
    >> Share


    Laryngoscope

  17. WONG EC, Castellanos CX, Grogan T, Holly T, et al
    Stellate Ganglion Blockade for Acute Pain Management After Transoral Robotic Surgery.
    Laryngoscope. 2026;136:1271-1276.
    >> Share

  18. IBRAHIM IM, Clementi E, Chisolm PF, Vasandani S, et al
    BMI, Sex as Predictors of Anterolateral Thigh Free Flap Thickness for Oropharyngeal Reconstructions.
    Laryngoscope. 2026;136:1286-1292.
    >> Share

  19. NAGAOKA M, Fukuzato S, Fukuda N, Kessoku H, et al
    A Practical Non-Robotic Surgery for Oropharyngeal Cancer in Resource-Limited Settings.
    Laryngoscope. 2026;136:1247-1252.
    >> Share

  20. HAMDAN AL, Alam E, Abou Raji Feghali P, Nasr A, et al
    Correlation Between Vocal Tract Dimensions and Patient Tolerance in Office-Based Laryngeal Surgery.
    Laryngoscope. 2026;136:1398-1402.
    >> Share


    Oral Oncol

  21. SUDARSON J
    Commentary on "A pilot study of a digital workflow for navigated tumor bed marking to reduce clinical target volume during adjuvant radiotherapy for oral squamous cell carcinoma".
    Oral Oncol. 2026;174:107884.
    >> Share

  22. CHU F, Benzi P, Tagliabue M, Mossinelli C, et al
    Rare laryngeal tumors: A retrospective bicentric study on 74 patients and systematic review.
    Oral Oncol. 2026;174:107852.
    >> Share

  23. WOJTERA BP, Beharry A, Salati V, Lambercy K, et al
    Long-term swallowing outcomes following transoral robotic surgery for oropharyngeal cancer - Five years and beyond.
    Oral Oncol. 2026;174:107876.
    >> Share

  24. STEELE K, Barnett C, Ladwa R, Donovan ML, et al
    Tumour microenvironment diversity of HNSCC and the molecular landscape of recurrent disease.
    Oral Oncol. 2026;174:107864.
    >> Share

  25. SANDSTROM K, Farnebo L, Hafstrom A, Westerborn A, et al
    Carcinoma of the parotid Gland: A Population-Based study of incidence and treatment outcomes in 1018 patients.
    Oral Oncol. 2026;174:107863.
    >> Share

  26. WANG XH, Cao LM, Zhu ZQ, Xiao Y, et al
    Cervical lymph node metastasis in oral squamous cell carcinoma: From metastatic patterns and risk factors to the development and validation of a predictive model.
    Oral Oncol. 2026;174:107860.
    >> Share

  27. LOVETT JT, Wotman MT, Westra WH, Ahn S, et al
    Long-Term outcomes of induction chemotherapy-guided reduced-dose chemoradiotherapy in poor-risk HPV-Positive oropharyngeal Cancer: Results from the sequential quarterback trials.
    Oral Oncol. 2026;174:107858.
    >> Share

  28. ADACHI M, Ohta S, Ishii A, Motohashi M, et al
    Contemporary management of the clinically N0 neck in oral squamous cell carcinoma.
    Oral Oncol. 2026;174:107839.
    >> Share

  29. LI C, Xiao X, Jiang H, Li B, et al
    Comparable survival after lobectomy and total thyroidectomy for T3b differentiated thyroid carcinoma: A population-based study.
    Oral Oncol. 2026;175:107891.
    >> Share

  30. XIN Y, Yang L, Liu C, Li D, et al
    Spatial transcriptomics of immune ecotypes for predicting immunotherapy outcomes in head and neck squamous cell carcinoma.
    Oral Oncol. 2026;175:107887.
    >> Share

  31. FAN M, Yin Q, Li L, Lian Q, et al
    Low-dose fractionated radiotherapy combined with induction chemotherapy in high-risk nasopharyngeal carcinoma: An open-label, randomized phase 2 trial.
    Oral Oncol. 2026;175:107888.
    >> Share


    PLoS One

  32. BEHKAR S, Golchini P, Kocamaz OF, Altundogan S, et al
    Evaluation of dentists' awareness, knowledge, and clinical practices regarding early-stage oral cancer lesions in Turkiye: A cross-sectional study.
    PLoS One. 2026;21:e0341849.
    >> Share

  33. MONTHER A, Al-Msari R, Saddawi-Konefka R, Fassardi S, et al
    CD47 blockade (ALX301) enhances immunoradiotherapy response in HPV negative head and neck squamous cell carcinoma.
    PLoS One. 2026;21:e0328031.
    >> Share


    Radiother Oncol

  34. CHEN L, Li J, Li K, Hu J, et al
    Corrigendum to "Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy". [Radiother Oncol. 190 (2024) 109985].
    Radiother Oncol. 2026;217:111439.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016